AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
ADORA2B | Adenosine A2b receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP2C2 | ATPase, Ca++ transporting, type 2C, member 2 | Enzymes Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GALT1 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT3 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT6 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6 (core 3 synthase) | Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT2 | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C2orf72 | Chromosome 2 open reading frame 72 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C9orf152 | Chromosome 9 open reading frame 152 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA2 | Carbonic anhydrase II | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CA4 | Carbonic anhydrase IV | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CD70 | CD70 molecule | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CDC42EP5 | CDC42 effector protein (Rho GTPase binding) 5 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
CEA | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000469926} | Predicted secreted proteins
| | | | | Tissue enhanced |
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CES3 | Carboxylesterase 3 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CKMT1B | Creatine kinase, mitochondrial 1B | Enzymes FDA approved drug targets Mitochondrial proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN23 | Claudin 23 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DHRS9 | Dehydrogenase/reductase (SDR family) member 9 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ERN2 | Endoplasmic reticulum to nucleus signaling 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FAM3D | Family with sequence similarity 3, member D | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FAM83E | Family with sequence similarity 83, member E | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM84A | Family with sequence similarity 84, member A | Predicted intracellular proteins
| | | | | Tissue enhanced |
FOXD2 | Forkhead box D2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
FRMD1 | FERM domain containing 1 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
FUT3 | Fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group) | Blood group antigen proteins Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
FXYD3 | FXYD domain containing ion transport regulator 3 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GALNT5 | Polypeptide N-acetylgalactosaminyltransferase 5 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
GJD3 | Gap junction protein, delta 3, 31.9kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GUCA2B | Guanylate cyclase activator 2B (uroguanylin) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HAVCR1 | Hepatitis A virus cellular receptor 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
HOXB9 | Homeobox B9 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXD11 | Homeobox D11 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HOXD12 | Homeobox D12 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
ITLN1 | Intelectin 1 (galactofuranose binding) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KLK15 | Kallikrein-related peptidase 15 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |